Tissue Genetics Inc. is a molecular diagnostics company with unique technology for improving the diagnosis, treatment and prevention of genetic diseases. Our proprietary biomarkers and novel test methods allow clinicians to diagnose genetic diseases fast, easily, accurately and economically. Our unique diagnostic tests will establish a new paradigm for screening of genetic diseases, providing critical information for determining the patients’ optimum course of care.
Recent news article in The Denver Post entitled "Bioscience Park at Fitzsimons Offers Fertile Ground for Seedling Biotech Companies"
Recent Publication in The Journal Of Clinical Oncology entitled "Detecting BRCA2 Protein Truncation in Tissue Biopsies to Identify Breast Cancers That Arise in BRCA2 Gene Mutation Carriers".
Recently received Phase II funding from the NIH.
Tissue Genetics on the Economic Report!! Click here to view! or visit www.youtube.com
